2020
DOI: 10.21203/rs.2.20334/v3
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Oil supplementation with a special combination of n-3 and n-6 long-chain polyunsaturated fatty acids does not protect for exercise induced asthma. A double-blind placebo-controlled trial.

Abstract: Background Many patients suffering from exercise-induced asthma (EIA) have normal lung function at rest and show symptoms and a decline in FEV 1 when they do sports or during exercise-challenge. It has been described that long-chain polyunsaturated fatty acids (LCPUFA) could exert a protective effect on EIA. Methods In this study the protective effect of supplementation with a special combination of n-3 and n-6 LCPUFA (sc-LCPUFA) (total 1.19 g/ day) were investigated in an EIA cold air provocation model. Prima… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…In the systematic review above, three-fifths studies were ≤3 weeks, 95 97 98 one study was 8 weeks, 96 and only one study was 6 months in duration. 99 Studies by Brannan, 100 Mickleborough et al 101 and Dreßler et al 102 were all ≤4 weeks, with varying doses (6 g, 5.2 g, 1.19 g/d). Only Mickleborough et al 101 (which had the highest dose) found improvements in lung function, reduced bronchodilator use, and reduced sputum inflammatory cytokines, while the others found no bronchoprotective effects of supplementation.…”
Section: Long Chain Fatty Acids In Asthma Prevention and Managementmentioning
confidence: 99%
“…In the systematic review above, three-fifths studies were ≤3 weeks, 95 97 98 one study was 8 weeks, 96 and only one study was 6 months in duration. 99 Studies by Brannan, 100 Mickleborough et al 101 and Dreßler et al 102 were all ≤4 weeks, with varying doses (6 g, 5.2 g, 1.19 g/d). Only Mickleborough et al 101 (which had the highest dose) found improvements in lung function, reduced bronchodilator use, and reduced sputum inflammatory cytokines, while the others found no bronchoprotective effects of supplementation.…”
Section: Long Chain Fatty Acids In Asthma Prevention and Managementmentioning
confidence: 99%
“…The ECC was performed according to the ATS guidelines for EIB [13] and as recently described [9][10][11]. The subjects ran in a cold chamber (Ilkazell Isoliertechnik, Germany) cooled to 2-4 °C (microprocessor-based controller, Dixell, Emerson Climate Technologies, United Kingdom) on a treadmill (Schiller Intertrack 8100 T Med, Germany) with an incline of 10 % for 6 minutes ( ≤ 12 years) or 8 minutes ( > 12 years).…”
Section: Exercise Challenge In a Cold Chamber (Ecc)mentioning
confidence: 99%
“…In this regard, EIB may be a sign of insufficient disease control in patients with bronchial inflammation [6,22,35]. Recently, we and others could show that exhaled nitric oxide (eNO) measurement is a valuable screening tool for EIB [4,[9][10][11][12]. An eNO cut-off value of 46.0 ppb detected EIB at 100 % in all suspected patients and an eNO cut-off value of 35.5 ppb in house dust mite (HDM) sensitized patients [10].…”
Section: Introductionmentioning
confidence: 99%